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RESEARCH ARTICLE
Longitudinal field studies reveal early 
infection and persistence of influenza A virus 
in piglets despite the presence of maternally 
derived antibodies
Pia Ryt‑Hansen1* , Inge Larsen4, Charlotte Sonne Kristensen3, Jesper Schak Krog1, Silke Wacheck2 
and Lars Erik Larsen1
Abstract 
A longitudinal study was performed in three Danish farrow to grower (30 kilos) herds over a 4‑month period to inves‑
tigate the dynamics and clinical impacts of influenza A virus (IAV) infections. In each herd, four batches consisting of 
four sows each with five ear‑tagged piglets were included. Nasal swabs and/or blood were sampled from the sows 
and/or the piglets prior to farrowing and at weeks 1, 3, and 5 and at the end of the nursery period. Clinical examina‑
tions were performed at each sampling time. The sows and piglets were tested for IAV and IAV antibodies in nasal 
swabs and blood samples, respectively. The results revealed three enzootically infected herds, where the majority of 
the pigs were infected during the first 5 weeks after birth. Infected piglets of only 3 days of age were detected in the 
farrowing unit, where the sows were also shedding virus. In all herds, low to moderate numbers of infected pigs (rang‑
ing from 3.6 to 20.7%) were found to be virus positive in nasal swabs at two consecutive sampling times. Furthermore, 
clinical signs of respiratory disease were associated with IAV detection. The findings of this study documented that IAV 
can persist in herds and that piglets as young as 3 days can be infected despite the presence of maternally derived 
antibodies.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Influenza A virus (IAV) is one of the most important 
viral pathogens in swine herds globally and is considered 
a significant cofactor in the porcine respiratory disease 
complex (PRDC) [1, 2]. IAV was first detected in Euro-
pean pigs in the 1970s [3] and has since been related to 
acute outbreaks of respiratory disease in swine herds that 
typically resolved within a few weeks [4, 5]. However, in 
recent years, a number of studies have shown that the 
dynamics of IAV infections have changed and that IAV 
can persist in herds. The change is probably a result of 
the increased herd size that ensures a weekly flow of 
naive individuals who can maintain the infection [6–12]. 
IAV is highly prevalent in Danish swine herds, and the 
results of the national passive surveillance program have 
revealed that the prevalence of IAV exceeds 45% in the 
diagnostic samples submitted from pigs with a history 
of respiratory disease. This makes IAV the most preva-
lent pathogen found in relation to PRDC in Denmark 
[13]. H1N1, H1N2 and H3N2 constitute the majority 
of the circulating IAV subtypes, and each subtype has 
a significant variety of different lineages with different 
genetic traits of avian (av), human (hu) or swine (sw) ori-
gin [14]. The most prevalent subtype in Denmark is the 
H1avN2sw, which has the avian-like hemagglutinin (HA) 
gene and the neuraminidase (NA) gene from the human-
like reassortant swine H3N2sw [15]. In 2010, pandemic 
A(H1N1)pdm09 appeared in Denmark and is now the 
second most prevalent subtype, constituting 20% of the 
strains. Furthermore, the internal genes of this strain 
have been incorporated into more than 80% of the most 
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prevalent strain H1avN2sw [13]. In addition to these 
dominating enzootic strains, a number of reassortants 
have been detected, including strains harboring the HA 
and NA genes from human seasonal flu strains, indicat-
ing that human-to-pig transmission takes place [13, 16].
The change in viral dynamics and the increased com-
plexity of the circulating variants pose a challenge for 
farmers and veterinarians when determining control 
methods [17]. Thus, there is a great need for studies 
designed to increase our knowledge of the transmission 
dynamics and impacts of IAV under field conditions. Few 
studies have focused on the transmission of IAV early in 
the farrowing unit [6], as most studies have initiated sam-
pling at an age close to weaning [11, 12] and have been 
performed as cross-sectional studies [18, 19]. The pri-
mary aim of the present study was to determine the prev-
alence of influenza-positive pigs over time by conducting 
an observational longitudinal cohort study in three Dan-
ish swine herds. A secondary aim was to investigate the 
association between virus-positive pigs and clinical signs. 
It is important to investigate the transmission dynamics 
and the clinical impact in pigs of this age because the pigs 
are highly susceptible and because this period includes 
the time when the pigs go from relying on passive immu-
nity to having an active immune response towards IAV. 
Furthermore, infected piglets at weaning may be the 
source of the infection in the nursery unit and further 
downstream.
Materials and methods
Ethical statement
This study was carried out in strict accordance with the 
guidelines of the Good Experimental Practices (GEP) 
standard adopted by the European Union. All experimen-
tal procedures were conducted in accordance with the 
recommendations given by the National Veterinary Insti-
tute of Denmark.
Selection of target herds
All herds should fulfill the following criteria: Minimum 
300 sows, production from farrowing-30 kilos, weekly 
production system, history of respiratory disease or labo-
ratory confirmation of IAV, no litter equalization of the 
ear-tagged piglets, no vaccination against IAV in the past 
year and no startup of vaccination of either sows or pig-
lets against IAV during the study period.
Screening for IAV in the target herds
Before a herd was included in the study, a screening 
for IAV was performed by testing nasal swabs from 5 
1-week-old piglets, 5 3-week-old piglets, 10 5-week-old 
weaners and 10 8-week-old weaners by reverse transcrip-
tion real-time PCR (RT-rtPCR).
Description of the included herds
Herd 1
This herd had approximately 900 sows and a farrow-
ing area divided into six units with no clear section-
ing between age groups. The piglets were weaned at 
4 weeks of age. When the piglets reached approximately 
15 kilos, they were moved to a separate stable until 
they were sold at 30 kilos. The herd was not included 
in the Danish SPF-system [20] but was declared free of 
porcine reproductive and respiratory syndrome virus 
(PRRSv). The herd had previously tested positive for 
H1avN2sw and had recurrent problems with respira-
tory disease. The herd did not use a strict all-in/all-out 
strategy in any of the units, and no quarantine stability 
was used for incoming gilts. In the herd, a high degree 
of litter equalization was used along with nursing sows. 
Stables were washed between production rounds in the 
farrowing unit and disinfected using calcium hydroxide.
Herd 2
This herd had approximately 900 sows and a farrow-
ing area divided into four units with no clear section-
ing between age groups. The piglets were weaned at 
4 weeks of age. When the piglets reached approximately 
20 kilos, they were moved to a separate stable until they 
were sold at 30 kilos. The herd had an SPF herd health 
status, indicating that the herd tested free of infections 
annually, including Mycoplasma hyopneumoniae, Act-
inobacillus pleuropneumoniae serotype, 2, 6, and 12, 
PRRSv type 1 and 2, Brachyspira hyodysenteriae, Pas-
teurella multocida, Sarcoptes Scabiei var. Suis and Hae-
matopinus suis. The herd had recurrent problems with 
respiratory disease but had never been tested for the 
presence of IAV. The herd did not use a strict all-in/all-
out strategy in any of the units, but a quarantine stable 
was used for incoming gilts. In the herd, a high degree 
of litter equalization was used along with nursing sows. 
Stables were washed between batches and disinfected 
using calcium hydroxide.
Herd 3
This herd had approximately 450 sows and a farrow-
ing area divided into two units with no clear section-
ing between age groups. The piglets were weaned at 
4 weeks of age and kept in the same grower unit until 
they were sold at 30 kilos. This herd was known to be 
IAV-positive and had recurrent clinical signs of respira-
tory disease. Similar to Herd 2, the herd had a blue SPF 
status, indicating that it was declared free of the same 
diseases as Herd 2. The herd only performed minimal 
litter smoothing and limited the use of nursing sows. 
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Gilts were recruited from the same herd. Stables were 
cleaned only once a year, without disinfectants.
Study design
This investigation was designed as an observational 
longitudinal cohort study in 3 Danish sow herds. In 
each herd, four batches of four conveniently selected 
sows were included with farrowing dates 1 week apart. 
Five piglets from each sow were randomly chosen by 
ear tagging of every third piglet in the litter at birth. 
The ear-tagged piglets were sampled with nasal swabs 
during weeks 1, 3, and 5 and again before being sold at 
approximately 30 kilos (at 10–12 weeks of age). As the 
piglets were not born on the same day, the actual sam-
pling date differed up to 4 days between pigs. Further-
more, the ear-tagged pigs were blood sampled during 
week 3 and at approximately 30 kilos (weeks 10–12). 
From sows, blood was sampled 2 weeks before farrow-
ing, and a nasal swab was taken 1  week after farrow-
ing (Table  1). A total of 16 sows and 80 piglets were 
selected for sampling at weeks 1, 3, 5 and 10–12 over 
a total period of 4  months in each herd. Ear-tagged 
piglets stayed with their own mother sow until wean-
ing. The sampling size was initially defined based on 
assumptions on body weight gains and production 
results, but these indicators were excluded from the 
final assessment due to inadequate quality of data from 
the herds.
Sampling
Nasal swabs were collected with a small or large sterile 
cotton swab (Medical Wire, UK) depending on the age 
of the animal. The swab was inserted and turned 360° 
in both nostrils of each pig. Afterwards, the swabs were 
immersed in Sigma Virocult media (Medical Wire, UK) 
and kept at 2–8 °C for a maximum of 2 days until RNA 
extraction.
Blood was sampled from vena jugularis of the sows 
and from vena cava cranialis of the piglets and stored 
in vacutainer serum tubes (Becton–Dickinson, Den-
mark) at 5 °C for a maximum of 2 days until they were 
centrifuged at 3000 rpm for 10 min, and the serum was 
frozen at −20° until further analysis.
Clinical observations
Each individual ear-tagged pig was examined for the 
presence of the following clinical signs at each sampling 
time: dyspnea, lacrimation, nasal discharge (s = serous, 
m = mucous and p = purulent), conjunctivitis, diarrhea 
and lameness. Additionally, the pigs had a body condition 
score specified ranging from 1 to 4. Every pen with an 
ear-tagged piglet had a coughing index (CI) calculated at 
every sampling time using a method based on a previous 
study on Mycoplasma hyopneumoniae [21]. The CI was 
calculated based on the number of coughs and sneezes 
over 3 min divided by the number of pigs in the pen.
Pooling of the samples and RNA extraction
The nasal swabs were pooled per litter with five samples 
in one pool corresponding to the five ear-tagged piglets 
from each sow. Four sows of each batch were also pooled. 
The Sigma Virocult media containing the cotton swab 
were vortexed and poured into a 1.5  mL tube (Eppen-
dorf ), wherefrom 100  µL was withdrawn for the pool. 
The pool was vortexed and centrifuged, and 200 µL was 
withdrawn and mixed with 400 µL RLT-buffer (QIAGEN, 
Copenhagen, Denmark) containing 2-mercaptoethanol 
(Merck, Darmstadt, Germany). The RNA was extracted 
from the sample using the RNeasy mini kit (QIAGEN) 
automated on the QIAcube (QIAGEN) according to 
instructions from the supplier.
Reverse transcription real‑time RT‑PCR
A previously published RT-rtPCR assay targeting the 
matrix gene of IAV [22] was used to determine if a pool 
was IAV positive. The OneStep RT-PCR Kit (QIAGEN) 
was used with the published primers. All PCRs were 
run on the Rotor-Gene Q (QIAGEN) using the follow-
ing program: 50  °C, 30  min; 95  °C, 15  min; and cycling 
45× (95 °C for 10 s, 60 °C for 20 s, 64 °C for 1 s, 68 °C for 
1  s, 72  °C for 30 s). A pool was considered positive if it 
had a ct value < 36. If a pool tested positive, the RNA was 
extracted from the individual samples of the pool using 
the same method as described above. The RNA was then 
again subjected to the RT-rtPCR assay described above to 
determine which individual pigs were positive for IAV.
All positive individual samples with a ct value < 31 
were then retested using a multiplex RT-rtPCR assay to 
determine the influenza A subtype. The QuantiTect Rev 
Table 1 Sampling program for sows and piglets 
Two weeks before farrowing Week 1 Week 3 Week 5 Weeks 10–12
Sows Blood samples Nasal swabs
Piglets Nasal swabs Blood sample + nasal swabs Nasal swabs Blood sam‑
ple + nasal 
swabs
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transcription kit (QIAGEN) was used with the primers 
and probes from a previous study [23] with a few primer 
adjustments, as listed in Table  2. PCR was run on the 
Rotor-Gene Q (QIAGEN) using the following program: 
50 °C for 20 min, 95 °C for 15 min, and cycling 40× (94 °C 
for 60 s and 60 °C for 90 s).
Serology
All blood samples were tested for antibodies against the 
NP gene of IAV, which is highly conserved between sub-
types, using a commercially available blocking ELISA 
(IDEXX; Influenza A Ab Test; IDEXX Laboratories, Inc.).
Descriptive and statistical analysis
The prevalence of influenza was determined at the lit-
ter, individual pigs and batch levels. The prevalence of 
the IAV in the litters of each herd was calculated based 
on the number of litters that were positive at each sam-
pling time from the total number of litters present at each 
sampling time. For the individual pigs, the prevalence 
was also based on the number of individual nasal swabs 
testing positive for IAV subtracted from the total amount 
of pigs present at each sampling time. In addition, “total 
prevalence” was estimated based on the total number of 
individual pigs testing positive at minimum one sampling 
time during the entire study period compared to the ini-
tial number of pigs at the beginning of the study. Finally, 
the batch level prevalence of IAV was calculated based on 
the number of individuals testing positive for IAV com-
pared to the total number of pigs included in the batch.
For each herd, a statistical analysis was performed 
comparing IAV-positive and IAV-negative individuals at 
a given age (week 1, week 3, week 5 and weeks 10–12) 
with the presence of one of the clinical signs registered at 
the individual level using the Chi-square test. This analy-
sis was also performed on the total clinical data from all 
three herds to evaluate an overall association. To reveal 
a possible significant difference between being a litter/
pen with at least one IAV-positive animal and being a 
negative litter/pen in relation to the coughing index, a 
Fisher’s exact test was performed on the means of the 
CIs. This test was performed both herdwise and on the 
total data of all three herds. A P-value below 0.05 was 
considered statistically significant. The statistics and 
graphs were completed using GraphPad Software [24] 
and Microsoft Excel.
Results
IAV subtypes
At the time of screening, Herd 1 tested positive for 
H1avN2sw, and this subtype was also found throughout 
the study period in all positive pigs except one 5-week-
old pig, which was infected with an H1avN1 subtype 
in the nursery. Herd 2 had A(H1N1)pdm09 detected at 
the time of screening and was later detected in both the 
farrowing unit and the nursery stable. H1avN2sw was 
identified at the time of the screening and was the only 
subtype circulating in Herd 3 in both the farrowing and 
nursery unit.
IAV—at the litter level
The results of the tests of the pooled samples, each 
including a single litter, indicated that the majority of the 
litters encountered IAV during the study period (Table 3). 
At week 1, each of the three herds had IAV-positive lit-
ters, with Herd 3 standing out, in that half of the tested 
Table 2 List of adjusted primers and probes used for the RT-PCR multiplex for subtyping 
“F” indicates the forward primer, “R” indicates the reverse primer, and “P” indicates the probe. Letters in “[ ]” indicate a locked nucleic acid (LNA). The letters in italics 
indicate the reporter and quencher.
Assay Primer/Probe Sequence (5′‑3′)
H1pdm H1fw2sw‑2 GAA GTT CAA GCC GGA AAT AGC A
H1av H1‑av‑P ROX-TCT GGT TAC GCA GCW GAT CAG AAA AGC AC-BHQ2
H3hu H3‑hu_mink‑F GAT GAT GGA GAA AAC TGC ACA CTA 
N2sw N2‑F GAG TAT GGT GGA CBT CAA AYA G
N2‑R TTG CGA AAG CTT ATA TAG GCA TGA 
N2‑P AF532-CCA TCA GGC CAT GAG CCT GAV CCA TA‑BHQ1
N2hu N2hu‑P AF532-T[+C]A [+A]CT CYA CAT AAA AGC ACC [+G]‑BHQ1
Table 3 Percentage of influenza A virus-positive pools 
from nasal swabs collected from pigs and tested by RT-PCR 
Herd 1 Herd 2 Herd 3
Positive pools
 Week 1 (4/16) 25% (3/15) 20% (8/16) 50%
 Week 3 (8/16) 50% (5/15) 33.3% (6/16) 37.5%
 Week 5 (3/16) 18.7% (7/15) 46.7% (10/16) 62.5%
 Weeks 10–12 (0/16) 0% (1/15) 6.6% (0/16) 0%
 Total (11/16) 69% (12/15) 80% (14/16) 87.5%
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litters were positive. In week 3, 33–50% of the litters were 
positive, and at week 5, the percentage of positive litters 
was 19, 47 and 63% in Herds 1, 2 and 3, respectively. In 
contrast, only one litter in total was positive at weeks 
10–12 (in Herd 2).
IAV—at the individual level
From all the positive pools, the individual samples from 
the five ear-tagged pigs were tested. The total % of IAV-
positive individuals was estimated by summing the num-
ber of infected individuals at each sampling time (weeks 
1, 3, 5 and 10–12), regardless of the batch (Table 4).
Due to mortality during the study, the total number of 
pigs included was less than planned and varied between 
herds and sampling times (Table 4).
Herd 1 showed the highest prevalence of infected indi-
viduals in the farrowing unit, with ~17% of the individu-
als being infected at weeks 1 and 3. After the piglets were 
transferred to the nursery unit, a much lower prevalence 
(4.8%) was observed at week 5, and none of the pigs 
tested positive at weeks 10–12.
Herd 2 had a relatively low prevalence of IAV at week 1, 
with only 9.2% of the piglets being infected; however, at 
week 3, the prevalence increased to 15.9% and peaked in 
the nursery, with 20.3% of the pigs being infected at week 
5. At weeks 10–12, only one pig tested positive for IAV.
Herd 3 had a more constant but high prevalence of IAV 
over the first three sampling times. Approximately 30% 
of the individuals were infected at each sampling time, 
and the highest prevalence (36%) was observed at week 
5 after transfer to the nursery unit. Consistent with the 
finding in Herd 1, all pigs were negative at weeks 10–12.
IAV—at the batch level
A difference in the time of infection was observed 
between the different batches, and no clear pattern was 
observed overall when comparing the three herds (Fig-
ure  1). However, in Herd 1 and Herd 3, the batches in 
which an IAV-positive sow was present, a high number 
of infected piglets at week 1 were observed (IAV results 
of the sows are shown below). In Herd 1, the prevalence 
of infected piglets at week 1 ranged between 21 and 35% 
in the two batches that had an IAV-positive sow (Batch 
2 and Batch 4), whereas the number was even higher 
in Herd 3, ranging from 47 to 55% of piglets in the two 
batches including an IAV-positive sow (Batch 2 and 
Batch 3). In Herd 3, all the piglets of the two IAV-positive 
sows were infected at week 1, whereas this was the case 
for one of the IAV-positive sows in Herd 1 (Additional 
file 1).
Shedding period and viral load
In all herds, several pigs tested positive for IAV at two 
consecutive sampling times. In Herd 1, two pigs were 
positive for IAV in weeks 1 and 3, and in Herd 2, one pig 
Table 4 Percentage of influenza A virus-positive pigs from 
nasal swabs collected from pigs and tested by RT-PCR 
a The total number of piglets present at the beginning of the study deviates 
from 80 due to mortality between birth and first sampling. Pigs that have been 
infected twice only count once in the total prevalence.
Herd 1 Herd 2 Herd 3
Week 1 17.3% (13/77a) 9.2% (6/65a) 34.6% (27/78a)
Week 3 16.2% (11/68) 15.9% (10/63) 29.5% (23/78)
Week 5 4.8% (3/62) 20.3% (12/59) 36% (28/78)
Week 10–12 0% (0/61) 2% (1/45) 0% (0/76)
Total 34% (26/77) 41.5% (27/65) 69% (54/78)
Figure 1 Percentage of IAV‑positive litters in the four batches 
of the three herds. The columns present the percentage of positive 
individuals in each batch at each sampling time (week 1, week 3, 
week 5 and weeks 10–12) for each of the three herds.
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was positive for IAV at both week 3 and week 5. In Herd 
3, a much higher prevalence was observed, with eleven 
pigs testing positive at two consecutive sampling times, 
and one pig even tested positive over three consecutive 
samplings (week 1 to week 5). Out of the ten remaining 
pigs in Herd 3, four were positive for IAV in weeks 1 and 
3, while six were positive in weeks 3 and 5. The overall 
prevalence of infected pigs that were positive over two 
consecutive samplings ranged from 3.6 to 20.7% of the 
total number of infected pigs in each herd.
In addition to pigs that were positive at two consecu-
tive samplings, one and 13 piglets were infected at two 
nonconsecutive sampling times (week 1 and week 5) in 
Herds 1 and 3, respectively. Detailed results are shown in 
Additional file 1.
The average ct value of the IAV-positive pigs in 
Herd 1 increased with age. In contrast, in Herds 2 and 
3, the lowest average ct values were detected at week 
5, which for both herds coincided with the peak of 
infected individuals.
IAV antibodies—ear‑tagged pigs
The prevalence of antibodies at weeks 3 and 10–12 of 
the ear-tagged pigs is shown in Figure 2. Herds 1 and 3 
showed a similar pattern, where 68–78% of the piglets 
were positive for IAV antibodies at week 3, whereas a 
significant decline was observed at weeks 10–12, where 
only 9–24% of the piglets were positive. Herd 2 showed 
a different pattern, with 31–36% of the pigs IAV anti-
body positive at both sampling times. No clear relation-
ship between virus positivity and serological status was 
detected, as both piglets originating from antibody-pos-
itive sows and pigs from antibody-negative sows became 
infected during the first 5  weeks after farrowing (Addi-
tional file 1).
IAV and IAV antibodies—sows
The majority (80–87.5%) of all included sows tested posi-
tive for antibodies against IAV 2 weeks before farrowing 
(Figure 2). In Herd 1, two sows were shedding IAV in the 
farrowing unit at week 1, and one of these sows was anti-
body negative 2 weeks before farrowing. The exact same 
pattern was observed in Herd 3, where two sows were 
also shedding IAV in the farrowing unit, and one tested 
negative for IAV antibodies 2 weeks before farrowing. In 
Herd 2, none of the tested sows were virus positive in the 
farrowing unit (Additional file 1).
Clinical signs
A statistically significant correlation was identified in 
Herd 1 between the IAV-positive litters/pens and an 
increased coughing index compared to the negative lit-
ters/pens (Table 5).
An additional statistically significant correlation was 
identified in Herd 2 between the presence of serous nasal 
discharge and the individual pig testing positive for IAV 
in the nasal swabs. This correlation was observed at week 
1 and week 5 and equally when looking at the total num-
ber of infected pigs (Table 6).
As 69% of all the individual pigs of Herd 3 were positive 
for IAV at some point during the study (Table 4), it was 
not possible to obtain a significant correlation for any of 
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Figure 2 Prevalence of IAV antibodies at the different sampling 
times of both sows and piglets of the three herds. The columns 
present the proportion of IAV seropositive sows 2 weeks before 
farrowing and seropositive piglets at weeks 3 and 10–12.
Table 5 Mean coughing index (CI) of virus-positive and 
-negative animals 
The results were considered significant at P < 0.05. “SD” is the standard deviation.
Mean CI Week 1 Week 3 Week 5 Total
Herd 1
 Virus positive 0.209 0.381 0.032 0.263
 SD 0.21 0.28 0.04 0.26
 Virus negative 0.026 0.223 0.05 0.089
 SD 0.03 0.19 0.03 0.13
 P‑value 0.007 0.21 0.44 0.006
Herd 2
 Virus positive 0.042 0.348 0.109 0.168
 SD 0.05 0.16 0.08 0.16
 Virus negative 0.109 0.56 0.088 0.234
 SD 0.12 0.53 0.05 0.36
 P‑value 0.40 0.41 0.48 0.48
Herd 3
 Virus positive 0.065 0.186 0.083 0.108
 SD 0.04 0.09 0.03 0.08
 Virus negative 0.090 0.239 0.106 0.166
 SD 0.07 0.26 0.05 0.2
 P‑value 0.40 0.64 0.45 0.26
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the clinical signs, even though several signs of respiratory 
disease were observed in the herd.
An overall analysis was performed to investigate 
whether the above mentioned associations were also 
apparent when accumulating the results of all three herds 
(Table 7). The coughing index and nasal discharge for all 
herds at each of the sampling times and as a total over all 
sampling times were calculated. A significant correlation 
between nasal discharge and the individual pig testing 
positive for IAV in the nasal swabs was observed both at 
week 1 and week 5 and when looking at the total number 
of infected pigs. However, no significant correlation was 
found with regard to the coughing index.
Discussion
The results of the present study revealed that IAV was 
clearly circulating in the farrowing unit, as well as in 
the start of the nursery period. The majority of the lit-
ters encountered IAV at some point during the study, 
and the true prevalence of IAV-infected individuals was 
probably higher since the pigs were not sampled every 
week. To our surprise, IAV was detected at a high prev-
alence even in piglets at 1 week of age, which to the best 
of our knowledge has not been described before. Over-
all, 98% of all the infected pigs tested positive within 
the first 5  weeks of life, even though more than 80% 
of the sows were seropositive for antibodies against 
IAV at farrowing. The high prevalence of seropositive 
piglets at week 3 (68–78%) in Herd 1 and Herd 3 indi-
cated that the piglets did receive MDAs from the sows. 
Nevertheless, the results also revealed that these pigs 
still became infected with IAV at an early age. This can 
either be due to the level and specificity of the MDAs 
absorbed by the piglets [25], which was not tested in 
this study, or due to a lack of protection through MDA, 
which several studies have indicated [11, 26–31]. Inter-
estingly, the piglets of Herd 2, which did not have a 
high rate of seropositive pigs at week 3 (31.5%), did not 
Table 6 Prevalence of nasal discharge of virus-positive and -negative animals 
The results were considered significant at P < 0.05.
Week 1 Week 3 Week 5 Total
Herd 1
 Virus positive 23% (3/13) 30.1% (4/13) 0% (0/3) 36.8% (7/19)
 Virus negative 12.5% (8/64) 47.3% (26/55) 50.8% (30/59) 35.9% (64/178)
 P‑value 0.58 0.43 0.26 0.861
Herd 2
 Virus positive 100% (6/6) 70% (7/10) 83.3% (10/12) 82.1% (23/28)
 Virus negative 44% (26/59) 32.7% (17/52) 34% (16/47) 37.3% (59/158)
 P‑value 0.03 0.062 0.006 < 0.0001
Herd 3
 Virus positive 77.8% (21/27) 91.3% (21/23) 78.6% (22/28) 82% (64/78)
 Virus negative 62.7% (32/51) 81.8% (45/55) 86% (43/50) 76.9% (120/156)
 P‑value 0.26 0.47 0.6 0.46
Table 7 Accumulated results of the clinical data from all three herds (CI and nasal discharge) 
Results were considered significant at P < 0.05. “SD” is the standard deviation.
Mean CI Week 1 Week 3 Week 5 Total
Herds 1, 2 and 3
 Virus positive 0.099 0.31 0.092 0.176
 SD 0.12 0.22 0.07 0.18
 Virus negative 0.072 0.348 0.078 0.17
 SD 0.09 0.39 0.05 0.27
 P‑value 0.43 0.70 0.52 0.87
Prevalence of nasal discharge
 Virus positive 65.2% (30/46) 69.6% (32/46) 74.4% (32/43) 69.6% (94/135)
 Virus negative 38% (66/174) 55.3% (88/162) 57% (89/156) 49.4% (243/492)
 P‑value 0.002 0.093 0.059 < 0.0001
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show an overall higher amount of infected individuals. 
Moreover, Herd 2 had the highest number of seroposi-
tive pigs by the end of the study, suggesting that more 
pigs from this herd have elicited an active immune 
response to IAV and thereby may be less susceptible 
to reinfection. This is in accordance with the results 
from Loeffen et  al. [30], who suggested that the pres-
ence of MDA in the piglets hindered an active immune 
response and that these pigs elicited a weaker immune 
response in response to a secondary IAV infection even 
with the same subtype.
The differences in the age of infection observed 
between the batches could be explained by the major-
ity of the batches being in different stables, presumably 
with different infection pressures, different mixing of 
age groups and other differences in flow and manage-
ment factors. Additionally, the presence and prevalence 
of IAV-positive sows could be a possible factor when 
considering batch-to-batch variation. In this study, it was 
observed that three out of the four positive sows also had 
a positive litter at week 1, which could indicate that the 
sows affect the transmission dynamics.
Overall, few pigs were infected at the end of the nurs-
ery period in three herds, indicating a good chance of 
having IAV-negative pigs at the time of transfer to the 
finisher section. However, at weeks 10–12, the prevalence 
of IAV antibody-positive animals was low, which could 
indicate that the majority of the pigs would not be pro-
tected against IAV reinfection in the finisher farm. Two 
previous studies have tested this hypothesis and tried to 
reinfect previously infected piglets with the same strain 
after the decline in MDA. In one of the studies, the pig-
lets were found to be primed, and no reinfection was pos-
sible [29], whereas the other study showed a weakened 
immune response in the presence of MDA and showed 
that reinfection was possible in some of the pigs [30]. 
The decline in IAV antibodies observed at the last sam-
pling time was in accordance with other studies that have 
found that MDA persists in piglets for approximately 
10 weeks [11, 12, 32, 33].
Nonconsecutive shedding of IAV was found in Herd 1 
and Herd 3, where piglets were shedding virus at week 
1 and again at week 5, with 4 weeks in between. Other 
studies investigating the IAV dynamics [12, 19] also 
found pigs that tested positive for the same IAV subtype 
at nonconsecutive sampling times, which suggested that 
reinfection with the same virus was possible. An expla-
nation for why we did not see more cases of reinfection 
could be the detection limit of the PCR assay, which 
would not detect pigs with a low viral load. The num-
ber of positive pigs over a minimum of two consecutive 
sampling times indicated that individual pigs had viral 
excretion for more than 2  weeks, which would suggest 
the presence of “prolonged IAV shedders”. However, as 
the pigs were not sampled daily, we cannot rule out that 
these pigs either became reinfected with IAV between 
the two sampling times or that an environmental con-
tamination of the sample could have occurred. More 
studies with daily samplings should be performed to 
prove the concept of prolonged IAV shedders. If we 
consider that the pigs were in fact true “prolonged IAV 
shedders”, it is important to take this into consideration 
in the control measures for IAV, as they will increase 
the transmission rate. Previous studies have found pro-
longed shedding time to be correlated to the presence 
of MDA at the time of infection [26, 27, 30]. This phe-
nomenon should be investigated in more detail because 
it may be an unwarranted effect of sow vaccination or 
immunity due to prior infections. A contributing fac-
tor to Herd 3 having a much higher prevalence of IAV 
may be related to the organization of the farrowing unit. 
Herd 3 only had two large farrowing stables, and so a 
division into age groups was impossible. Herd 1 and 
Herd 2, on the other hand, had a higher number of far-
rowing stables, making it possible to keep the youngest 
and the oldest pigs more separated, even though a clear 
sectioning was not possible. This underlines the impor-
tance of separation of age groups and strict all-in/all-out 
strategies when fighting viral pathogens such as IAV 
[34].
The subtypes found in the three herds represent the 
subtypes that are currently circulating in Denmark. The 
most prevalent subtype H1avN2sw was found in Herds 1 
and 3, and Herd 1 also had one pig in the nursery unit 
that tested positive for a different subtype H1avN1av. 
As none of the pigs in the farrowing unit were infected 
with this subtype, combined with the low seroprevalence 
at the end of the nursery period, this different subtype 
poses a risk of a secondary IAV infection.
Although a descriptive study is not designed to evalu-
ate any associations, the observations regarding influenza 
and clinical signs were analyzed, and the clinical data 
showed that there was a significant correlation between 
being positive for IAV in nasal swabs and clinical signs 
of respiratory disease. In Herd 1, an increased cough-
ing index was observed. However, this correlation was 
not observed when accumulating the results of all three 
herds. In Herd 2, a significant correlation was observed 
between serous nasal discharge and the presence of IAV, 
and this correlation was also significant when accumulat-
ing the results of all three herds. This indicated that IAV 
had an impact on health in these enzootically infected 
herds.
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IAV was detected in two out of 16 sows in both 
Herds 1 and 3, which showed sows as a potential 
source of exposure of the piglets in the herds and as a 
possible source of new IAV introductions into the far-
rowing unit as previously proposed [11, 35]. All piglets 
from three of the four IAV shedding sows tested posi-
tive for IAV at week 1, which could indicate that the 
virus was transmitted between piglets and sows. How-
ever, another explanation could be that both sows and 
piglets were infected by aerosols and fomites, since the 
infection pressure in the farrowing unit was quite high. 
Cases in which both sows and piglets are found posi-
tive at the same time need to be further investigated 
to evaluate the risk of sows transmitting influenza to 
piglets during the farrowing stage.
In each herd, one of the IAV-positive sows tested 
negative for IAV antibodies 2 weeks before farrowing, 
and 1 week after farrowing, these sows were shedding 
IAV, which indicated that the sows were most likely 
infected at entry into the farrowing unit, where an 
abundant circulation of IAV was present. These results 
emphasize the importance of having a clear introduc-
tion strategy of incoming gilts because gilts may either 
be seronegative if they originate from a non-IAV-
infected herd or have antibodies against a different 
variant of IAV. Exposure to IAV by vaccination before 
insemination and before farrowing should be consid-
ered to reduce the risk of the sows being infected dur-
ing pregnancy or when entering the farrowing unit. 
Indeed, gilts have previously been shown to be a con-
tributing factor to IAV persistence at the herd level 
[18, 36]. Quarantine measures and testing of incoming 
gilts should be performed to avoid the introduction 
of new IAV strains into the herd, causing an epizootic 
outbreak.
All the herds included in the study were enzootically 
infected with IAV, and signs of clinical impacts were 
evident. A high infection pressure of IAV was discov-
ered in both the farrowing unit and the start of the 
nursery period. Interestingly, these results indicated 
that most of the IAV infections occurred at an age 
when the piglets were considered clinically protected 
through MDA. Overall, 98% of all the infected piglets 
became infected before reaching 6  weeks of age. This 
indicated that MDAs might not provide optimal pro-
tection against IAV, and other control measures, such 
as improved external and internal biosecurity, should 
be considered when selecting a strategy for controlling 
IAV. Finally, sows should be considered highly impor-
tant players in ongoing IAV transmission and as a pos-
sible source of new IAV introductions.
Additional file
Additional file 1. Overview of the antibody and virus shedding status 
of the sows and ear‑tagged pigs at the different sampling times. The 
table shows the four different batches of sows and their respective piglets 
at the different sampling times. The numbers indicate the ear tag number 
of the piglets, while the sows are numbered from 1–16. Italic letters 
indicate that the pig was not blood sampled, bold letters indicate an IAV 
antibody seropositive ear‑tagged pig or sow, and normal letters indicate 
an IAV antibody seronegative ear‑tagged pig or sow. “+IAV” indicates the 
nasal swab of the individual pigs or sows that tested positive in the quan‑
titative real time RT‑PCR targeting the matrix gene of IAV. If a box is empty, 
it indicates that the ear‑tagged pig is either dead or not sampled.
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